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Abstract
Background Mobile health (mHealth) services cannot easily
adapt to users’ unique needs.
Purpose We used simulations of text messaging (SMS) for
improving medication adherence to demonstrate benefits of
interventions using reinforcement learning (RL).
Methods We used Monte Carlo simulations to estimate the
relative impact of an intervention using RL to adapt SMS
adherence support messages in order to more effectively ad-
dress each non-adherent patient’s adherence barriers, e.g.,
forgetfulness versus side effect concerns. SMSmessages were
assumed to improve adherence only when they matched the
barriers for that patient. Baseline adherence and the impact of
matching messages were estimated from literature review.
RL-SMS was compared in common scenarios to simple re-
minders, random messages, and standard tailoring.
Results RL could produce a 5–14% absolute improvement in
adherence compared to current approaches. When adherence
barriers are not accurately reported, RL can recognize which
barriers are relevant for which patients. When barriers change,
RL can adjust message targeting. RL can detect when mes-
sages are sent too frequently causing burnout.
Conclusions RL systems could make mHealth services more
effective.
Keywords Medication adherence .Mobile health . Text
messaging .Simulationmodels .Chronicdiseasemanagement
Introduction
Patient non-adherence to medications for chronic disease
management is a major cause of preventable morbidity, mor-
tality, and excess healthcare spending. As many as half of all
chronically ill patients fail to take their medications as pre-
scribed, contributing to nearly 100,000 premature deaths an-
nually, as well as $290 billion in annual healthcare costs [1–3]
and more than a 10% increase in hospital admissions for older
adults [4].
While forgetfulness is one major challenge to medication
use, non-adherence often is intentional, due to patients’ skep-
ticism about the medication’s potential benefits, or concerns
regarding side effects or other negative consequences of long-
term pharmacotherapy [5–7]. Patients often report multiple
reasons for not taking their medication as prescribed [5].
Those reasons differ among patients and can change over time
as patients’ health beliefs are influenced by factors such as
their receipt of health information or changes in their health
status [8, 9].
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Mobile health (mHealth) interventions such as patient text
messaging (short message service or SMS) can deliver fre-
quent prompts and health information to improve adherence
[10–16]. Two large trials in Kenya have shown that SMS
messages can improve antiretroviral adherence among pa-
tients with HIV/AIDS, with one of those trials demonstrating
significant improvements in viral suppression [17, 18]. Stud-
ies from other countries also demonstrate that SMSmessaging
may improve medication adherence [13–16]. Some of the
most successful text messaging adherence interventions have
focused on medication reminders [19].
One well-established, evidence-based technique to ensure
that patients using mHealth support services receive the infor-
mation they need is to tailor messages according to the char-
acteristics of the user [20]. Most studies of tailored health
communication use comprehensive baseline assessments to
determine what information will be most impactful for which
pa t i en t s [20 ] , t yp i ca l l y focus ing on pa t i en t s ’
sociodemographic characteristics, clinical history, health be-
liefs, and other determinants of self-care behavior. Message
tailoring can significantly improve the effectiveness of health
behavior change messages, including messages addressing
medication underuse [21–23].
Despite its demonstrated benefits, the effectiveness of tai-
lored communication may be limited if the assessments used
to tailor information fail to address key determinants of users’
behavior, or if valid patient information cannot be collected
due to psychometric limitations in the measures or biases in
patient reports. For some behaviors, such as medication ad-
herence, accurate data are often lacking about what causes
patients to fall short of self-care goals [24]. Patients’ need for
health information may change over time as they master skills
or develop new concerns, and repeated tailoring to accommo-
date those changes is challenging. Finally, studies have shown
repeatedly that patients can become desensitized to health
communication [25–28], and current approaches to tailored
adherence support typically cannot detect patient burnout or
adapt message content and frequency so that services remain
engaging and effective. The next generation of chronic disease
behavior change services will need new strategies for building
on the successes of tailored messaging based on up-to-date
evidence regarding the content and mode of communication
that are most effective for each individual.
Reinforcement learning (RL) is a field of artificial intelli-
gence that presents new opportunities to automatically adapt
mobile health communication based on feedback from pa-
tients about the impact of different types of messages with
respect to attaining a given health or behavioral goal. RL
algorithms applied to mobile health communication for ad-
herence support can use information about the effectiveness of
prior messages addressing each patient’s reasons for non-
adherence while continuing to strategically explore patients’
responses to messages addressing other potential adherence
challenges that have yet to be identified. RL has been applied
extensively in robotics, control systems, and resource alloca-
tion tasks [29, 30], and RL algorithms are common in digital
commerce, including web advertisement; online news article
selection; or product recommendation by companies such as
Google [31], Yahoo [32], Amazon, and Netflix. Applications
of RL to human-centered tasks related to behavior change are
rare [33–35], and to our knowledge, only a few published
papers have described the use of RL in mobile health disease
management support [36].
The purpose of this study was to demonstrate the ways in
which RL could be used to adapt the content and frequency of
SMS messages to promote adherence among individuals tak-
ing a medication regularly for a chronic medical problem. To
that end, we conducted Monte Carlo simulations estimating
the impact of an RL-driven SMS adherence support tool
relative to other common approaches to designing mobile
health messaging systems, such as focusing specifically on
patient reminders or tailoring communication using a baseline
survey. Monte Carlo simulations allow potential impacts of a
healthcare intervention or policy to be evaluated without the
costs of service development and deployment, patient enroll-
ment, and outcome measurement in a real-world trial [37–39].
A strength of simulations is that intervention effects can be
estimated in the context of differing scenarios (e.g., whether or
not patients misreport their adherence barriers, making stan-
dard tailoring more difficult) as well as in the context of
random variability in key parameters, such as patients’ daily
adherence behavior. Through the simulations presented here,
we estimated the relative performance of RL compared to
three common approaches to mobile health messaging and
in the context of real-world challenges to the effectiveness of
SMS behavior change services, including a change in patients’
adherence barriers over time and decreased intervention effec-
tiveness when some patients become desensitized to messages
that are sent too frequently.
Methods
Components of a Reinforcement Learning System for SMS
Adherence Support
An RL system is composed of four functional units: (1) a set
of action choices (in this case, the types of SMS messages
addressing various potential reasons for non-adherence); (2) a
means of obtaining feedback or “reinforcement” about the
outcome of interest following each action choice, i.e., the
“reward” in RL terminology; in the case of medication use,
the reward can be defined as an ongoing measure of medica-
tion adherence during successive intervals; (3) Additional
information about the “state” or context within which action
choices are made, such as patients’ characteristics affecting
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adherence as well as information about patients’ prior history
of interaction with the system; and (4) an RL computational
agent (the RL “engine”) that adapts probabilistic action
choices based on the state, action, and reward data that are
accumulated over time. Each of these components is described
below. Additional technical details about RL are included in
the Electronic Supplementary Material (ESM).
Action Choices Action choices represent the set of potential
interventions available to the RL system at each time point.
For the simulations described here, we defined action choices
as the choice to send an SMSmessage addressing one of three
possible reasons for medication non-adherence. Specifically,
we reviewed the literature [6, 40, 41] and identified three
common barriers to appropriate medication use: (1) patients’
beliefs about their disease and its implications for their health
and well-being, e.g., beliefs that their illness is not serious or
that their risk for complications is minimal; (2) patients’
beliefs about their medication, e.g., that the medication cannot
change their long-term course of illness or that it will cause
side effects; (3) patients’ need for strategies to address forget-
fulness in taking their medication. In the simulations, the RL
system was designed to “learn” for each patient which mes-
sage type or action was most effective in promoting adher-
ence; and (4) in the third simulation below, examining the
impact of message fatigue, a null message (i.e., not sending
any message), was considered a fourth action choice so that
the system could learn the frequency of messaging that was
most effective for each patient.
Adaption Based on Feedback RL systems adapt by seeking to
optimize a numerical outcome or “reward.” Operationally, an
SMS medication adherence support system using RL would
need a “sensor” for collecting data about patients’ medication
taking following each message sent to the patient as well as a
mathematical model for translating those adherence data into a
score that the system uses as its reward to evaluate the impact
of those action choices. A sensor could be something simple,
such as an SMS system with which patients could repeatedly
self-report their adherence using a numerical rating scale. For
the simulations presented here, we assumed that the RL sys-
tem would be informed about patients’ adherence using daily
pill bottle openings provided automatically via a medication
electronic monitoring system (MEMS) [42–45].
State Information When making action choices, some RL
algorithms can take into account baseline information about
each patient as well as information gathered during the history
of interaction between the patient and the system. Such “state”
information summarizes what is important to action selection.
State parameters can be thought of as “effect modifiers” that
influence the expected impact of a given action on patients’
adherence. In SMS intervention design, state information
could include information such as changes in adherence after
sending previous messages, adherence barriers or health be-
liefs reported at baseline, or the patient’s demographic char-
acteristics. RL systems learn the best mathematical function
relating state variables with probabilistic action choices. By
learning an action-selection policy from prior interactions
with users and applying that policy to future interactions with
patients who share similar characteristics as recorded in their
vector of state information, RL systems can learn more quick-
ly how best to target messages so as to maximize the impact
on the “reward.”
The RL Engine There are several types of RL algorithms that
could be used to process reward data and drive SMS adher-
ence support message-selection choices [29, 46–48]. Regard-
less of this choice, all RL systems must address two funda-
mental problems: (1) balancing exploration of relatively un-
tested action choices versus exploitation of information about
choices that have already been shown to be impactful and (2)
accounting for delayed effects of a given action choice on
patients’ future adherence behavior. This latter problem is
particularly relevant in mobile health services supporting be-
haviors such as medication adherence, since information from
SMS adherence messages hopefully affects patients’ adher-
ence not only the day the message was received but also the
patient’s long-term ability to self-manage their chronic dis-
ease. One subset of RL approaches (known as “bandit” algo-
rithms) assumes that an SMS message sent today influences
only the patient’s likelihood of adherence that same day, i.e.,
the message will have no residual impact on their adherence in
the future. Other algorithms (e.g., algorithms based on partial-
ly observable Markov decision processes or POMDP’s) esti-
mate a parametric model for patients’ underlying pattern of
behavior and use that knowledge to account for long-term
effects. These differences between algorithms can contribute
to the speed with which an RL system can effectively adapt to
each patient’s unique needs (i.e., the number of patients and
patient interactions needed to optimize message choices) as
well as the maximum impact that the system may have across
patients and over time. Parametric models can be slow to
learn, while algorithms that learn quickly may not have the
greatest long-term effect. In the simulations that follow, we
used a contextual bandit algorithm, LinUCB (see ESM for
more information), to illustrate the way in which an RL-
supported SMS adherence program can adapt quickly to each
patient’s needs and have a relatively important impact even in
the absence of a parametric model of patients’ adherence
behavior [49].
Monte Carlo Simulations
To evaluate the performance of RL-based adherence messag-
ing relative to other approaches, we conducted three Monte
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Carlo simulations. For each simulation, we assumed that
patients’ adherence behavior was determined by the extent
to which they experienced three adherence barriers, represent-
ed by the three “α(barrier)” terms in the following formula:
P adherenceð Þ ¼ α diseaseð Þ  α medicineð Þ  α rememberð Þ
where P(adherence) is the probability that a patient takes his
or her medication correctly each day, α(disease) represents the
extent to which the patient believes that his or her illness is
important to treat (ranging from values of 0 for not at all
important to 1 for extremely important), α(medicine) represents
the extent to which the patient is concerned about the negative
consequences of his or her medication use (ranging from 0 for
extremely concerned to 1 for not at all concerned), and α-
(remember) represents the likelihood that the patient remembers
to take his or her medication on a given day (ranging from 0
for will not remember to 1 for will definitely remember).
For example, if a patient is only 80 % convinced about the
importance of treating his or her illness (i.e., α(disease)=0.80),
the patient is only 70 % concerned about taking the medica-
tion (i.e., α(medicine)=0.70), and if the patient has only a 90 %
probability of remembering to take the medication assuming
he or she intends to do so (i.e., α(remember)=0.90), then that
patient’s probability of taking medication on a given day
would be as follows:
1ð Þ : P adherenceð Þ ¼ 0:80 0:70 0:90 ¼ 0:504
In the simulations presented here, we assumed that the
patient sample included 20 patients whose only adherence
barrier was a doubt about the disease’s severity, 20 patients
whose only barrier was a concern about the safety and efficacy
of the medication, and 20 patients who both had doubts about
disease severity as well as problems with forgetfulness. Based
on a literature review [4, 5, 8, 9, 50, 51], we assumed that the
value of each α(barrier) in our simulations was 0.65. Studies for
medications treating hypercholesterolemia, osteoarthritis, car-
diovascular disease, and type 2 diabetes report adherence rates
ranging from 50 to 72 % [3, 51]. Other studies including
conditions such as bladder disorders and glaucoma have
found adherence rates below 40 % [2]. Given that all three
α(barrier) terms=0.65, the baseline adherence rate for the over-
all sample of simulated patients was in this range, i.e., 57 % or
the average of 65 % for the 20 patients with only doubts about
their disease’s severity, 65 % for the 20 patients with only
medication belief concerns, and 42.25 % for the 20 patients
with both disease belief as well as forgetfulness problems.
Patients’ actual adherence on a given day was assumed to vary
around their own average adherence level, according to ran-
dom variation in the relevant α(barrier) terms, with each day’s
value for each patient drawn from a Gaussian distribution with
a mean of 0.65 and a standard deviation of 0.30.
SMS messages were assumed to impact adherence only if
they addressed the patient’s underlying reasons for non-
adherence as expressed by that person’s three α(barrier) values.
For example, we assumed that a reminder message would
have no impact if the patient in fact was not forgetful but
rather was non-adherent because of unaddressed concerns
about the medication’s safety. When a given SMS message
did address one of the patient’s reasons for non-adherence, the
magnitude of the SMS message effect or “β(match)” was cal-
culated as a multiplicative improvement in the relevant α-
(barrier). For example, if β(match)=0.6 and a patient only had
medication concerns with α(medicine)=.65, then their α(medicine)
would change to the following:
2ð Þ : α medicineð Þ ¼ 0:65þ 0:6 1:0−0:65ð Þ ¼ 0:86
In the absence of an empirical evidence for differences in
the effect size of SMS messages addressing each of the three
adherence barriers, we assumed that the effect of a matching
SMS message was the same for all three. The magnitude of
β(match) used in the simulations presented below was based on
the improvement in adherence reported in SMS adherence
trials, i.e., 12 to 16 % [17, 21, 50, 51]. For example, Pop-
Eleches et al. [17] found that weekly short reminders could
improve adherence by up to 13 % over the control group after
48 weeks, and Petrie et al. [21] showed that text messages
tailored to patient’s underlying adherence barriers could im-
prove adherence up to 15 % over a control group. To ensure
that our simulations generated results that were comparable to
these outcomes, we assumed that each day, the actual value of
β(match) for each patient was selected at random from a normal
distribution with a center of 0.7 and a standard deviation of
0.3.
Given these assumptions, the goal of the RL-supported
messaging system was to increase the intervention’s effective-
ness over time via an increased likelihood of a match between
the type of message sent to each patient on each day and the
patient’s adherence barriers. RL sought to increase the match
success rate by modifying the probability of sending a mes-
sage addressing each of the three barriers, based on feedback
about that patient’s adherence following prior choices by the
RL engine as to which message type would be most effective.
More details about the characteristics of each simulation are
presented in Table 1 and ESM. The results of the simulations
are presented graphically in Figs. 1, 2, and 3 as changes in the
proportion of patients who took their medication each day
over the course of a 180-day intervention period. Estimates for
each day of adherence support were averaged over 100 inde-
pendent runs, with key parameters being drawn from Gauss-
ian distributions, as noted above.
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We compared the behavior of the RL-SMS adherence
support service to three common alternatives to delivering
SMS messaging interventions: (1) SMS messages serving
only as medication adherence reminders, (2) SMS messages
addressing each of the three potential barriers to adherence but
sent randomly so that each patient received all message types
on random days, and (3) SMS messages tailored to patients’
adherence barriers as reported in a baseline survey. The RL
algorithm initially weighted its choice of messages according
to the baseline information about the patient’s barriers—
similar to the tailored approach. However, unlike tailoring,
message choices for RL were selected from a probability
distribution in which messages addressing other potential
adherence barriers were selected with a small probability, so
that RL could “explore” these choices, learn from subsequent
adherence feedback, and adjust message targeting
accordingly.
The relative efficacy of the RL-based messaging system
was evaluated in three scenarios, representing possible situa-
tions that could limit the efficacy of current approaches: (1) a
Fig. 1 Adherence rates achieved
using four different message-
selection strategies when a third
of the population does not
accurately self-report their non-
adherence barrier
Fig. 2 Adherence rates achieved
using four different message-
selection strategies when a third
of the population change their
non-adherence barrier on day 90
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scenario in which some patients’ actual barriers to medication
adherence are not accurately measured at baseline, (2) a sce-
nario in which some patients’ reasons for non-adherence
change during the course of intervention, and (3) a scenario
in which patients experiences SMSmessage fatigue and begin
to tune-out messages that come too frequently. In the first
scenario, we assumed that patients who were actually con-
cerned about their medication’s safety instead reported at
baseline that their problem was forgetfulness. In the second
scenario, we examined what would happen when patients
who originally had doubts about their medication’s safety
instead developed doubts about their disease severity roughly
halfway through the intervention period. In each of these two
scenarios, we assumed that patients received SMS messages
daily.
In the third scenario, we assumed that patients experienced
message burnout when they received messages too frequently
and that “too frequently” meant that they received a message
after having received a message on each of the two previous
days. For patients experiencing message burnout, we used a
multiplicative fatigue factor that diminished the daily effect of
a well-targeted message (recall that mismatched messages
were assumed to have no effect). Specifically, we assumed
that the effect of a given SMS message matching the patient’s
adherence barrier decreased 5 % each day that the patient was
fatigued. For patients in the three non-RL comparison groups,
we assumed that the SMS system continued to send messages
daily despite message fatigue. In contrast, in the RL-supported
program, the system was designed to “learn” automatically to
adapt to message burnout by evaluating the impact of sending
one of the three message types versus sending no message on
a given day to prevent message fatigue. Each day that the
patient was not fatigued, the impact of a well-matched mes-
sage increased 10 % until it reached its maximum level. See
the ESM for more details.
Results
Simulation #1: Adaptation to Misreported Reasons
for Non-Adherence
As shown in Fig. 1, in the initial 10 days of messaging, a
tailored system resulted in higher rates of improvement in
medication adherence than the alternative messaging ap-
proaches. During that initial period, the RL system (lacking
experience from which to learn) began by randomly sending
some messages to patients and therefore matched their adher-
ence support needs less frequently than the tailored approach.
However, with greater experience, the RL system was able to
target messages effectively according to their impact on each
patient’s actual adherence, i.e., regardless of the patient’s
reported reasons for non-adherence at baseline. In contrast,
the tailored approach continued to send mismatched messages
to simulated patients who reported forgetfulness at baseline
but who actually had concerns about their medication’s safety.
As a consequence, the overall improvement in adherence for
the tailored system was less than for the RL system at
180 days.
The simple reminders performed worse than all other mes-
saging strategies because only one third of the simulated
sample had forgetfulness as an adherence problem, and those
patients also had concerns about their disease severity.
Fig. 3 Adherence rates achieved
using four different message-
selection strategies when there is
message fatigue
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Random messaging performed slightly better than simple
reminders, since each message had at least a one third chance
of being relevant for a particular patient. For simulated pa-
tients with both disease belief and memory barriers, each
random message had a two thirds chance of being relevant.
At the end of 180 days, the estimated daily adherence rate was
78 % for the RL messaging system, 73 % for the tailored
system, 67 % for random messaging, and 66 % for simple
reminders.
Simulation #2: Changes Over Time in Patients’ Reasons
for Non-Adherence
When assuming that simulated patients did in fact accurately
report their reasons for non-adherence at baseline, the tailored
approach, because it was immediately able to match adher-
ence support messages to patients’ needs, exceeded all other
approaches in the initial period of intervention and continued
to do so for the first 90 days (Fig. 2). During that period, the
RL approach progressively improved relative to random mes-
saging and simple reminders but still performed worse than
tailored messages. However, when simulated patients who
originally had concerns about their medication’s safety devel-
oped doubts about their disease severity halfway through the
intervention period, the tailored approach experienced a sig-
nificant drop in effectiveness for users who thereafter had a
mismatch between their message tailoring and their actual
need for adherence support. The RL approach also experi-
enced a drop in effectiveness at 90 days, since “lessons
learned” in the first 90 days led the system to send messages
incorrectly to patients whose adherence barriers changed.
However, as shown in Fig. 2, the RL system was able to adapt
to the change in patients’ adherence barriers and began to
outperform the tailored approach as well as the other two
approaches around day 100. At the end of 180 days, expected
daily adherence rates were 78 % for the RL system, 73 % for
tailored messaging, 68 % for random messages, and 66 % for
simple reminders.
Simulation #3: The Impact of Message Fatigue
As shown in Fig. 3, message fatigue led to diminishing
intervention impact among patients receiving tailored mes-
sages, randommessages, or simple reminders. This is because
these messaging strategies were unable to adapt to the fact that
when fatigued, the impact of well-targeted messages was
progressively less. This resulted in a steady drop in the adher-
ence rate for the three comparison groups, until the adherence
rate in each group reached the baseline rate. In contrast, the RL
messaging strategy was able to learn that the highest adher-
ence rate for these simulated patients was achieved by repeat-
ing the pattern of sending two consecutive well-targeted mes-
sages followed by not sending a message on the third day.
Initially, the adherence rate in the RL messaging group de-
clined as the RL system learned how patients responded (and
in the process, elicited fatigue in some patients). However, by
20 interactions per patient, the adherence rate in the RL group
started rising. At the end of 180 days, the expected daily
adherence rate was 70 % for the RL system while the com-
parison groups returned to their baseline adherence rate of
57 %.
Discussion
We used Monte Carlo simulations and information about the
effectiveness of adherence support services from prior trials to
estimate the impact of an RL-based SMS adherence support
tool compared to other common approaches to SMS adher-
ence messaging. Our results indicate that RL is able to learn to
personalize messages to individuals based on their true under-
lying causes for non-adherence, adapt to changes in the un-
derlying causes for non-adherence over time, and adapt the
frequency of messaging so as to avoid message fatigue. The
RL system was able to outperform current approaches to
designing SMS adherence interventions given reasonable as-
sumptions regarding each approach’s effectiveness when
SMS messages matched patients’ adherence barriers and as-
suming a relatively small sample of patients. These results
affirm our underlying hypothesis that RL-based systems can
overcome some of the limitations of current approaches to
mHealth service design including approaches that tailor health
communication via fixed information collected about patients’
health beliefs at baseline. RL systems learn from increasing
experience. As a consequence, systems will become increas-
ingly effective as the number of patients and patient interac-
tions grows. Because mHealth interventions can be expensive
to create but less expensive to maintain, they become more
efficient in the context of larger sample sizes, and therefore,
RL may be ideally suited to situations in which mHealth
programs are likely to be deployed.
It is important to emphasize that the scenarios explored in
the current simulation trials are common in chronic disease
management. For example, it is well known that patients often
misreport their adherence barriers [19], and time-pressed cli-
nicians may not be able to administer extensive tailoring
surveys at program entry. For both of these reasons, RL
services that require little tailoring information at baseline
are an attractive alternative. Moreover, changes in patients’
health status and adherence barriers are the hallmark of chron-
ic illness, and researchers have had difficulty identifying
services that can continue to be engaging and relevant in order
to maintain health benefits over the long-term. Because RL-
based behavior change services continually adapt according to
what is working for each patient, they represent a more
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patient-centered and potentially more effective alternative to
current approaches.
“Message fatigue” is a major problem in chronic disease
management [25–28]. Fatigue has not been addressed ade-
quately because tolerance for frequent messages likely varies
across patients, and addressing fatigue means balancing that
problem with the need to make interventions as intensive as
possible. Unlike less flexible approaches to messaging, RL
can use feedback from patients to develop schedules that meet
each individual’s unique needs and preferences for
information.
Our simulations leave open a number of challenging ques-
tions. Consistent with the underlying motivation for an adap-
tive approach, generalizations about the impact of RL behav-
ioral interventions relative to standard messaging strategies
are likely to be of limited relevance for a given application,
due to the diversity of: the clinical problems for which an
adaptive intervention might be useful, the characteristics of
patients with whom these interventions could be applied, and
the action choices that could be available to the RL system.
Multiple empirical studies will be needed addressing a wide
range of health behavior challenges to fully understand where
and to what degree RL systems can improve behaviors over-
and-above current, deterministic interventions.
Nevertheless, some general conclusions can be drawn
about the characteristics of RL-based interventions that are
likely to lead to a more successful adaptation to patients’
needs and therefore greater effectiveness. Action choices need
to be defined so that they represent distinct and meaningful
alternatives that behavioral theory suggests may have varying,
measurable impacts on outcomes across patients and over
time. To the extent possible, the “reward” signal should be
reliable, tightly linked to the action choices made by the RL
system, and reported frequently enough to allow for rapid and
successful intervention adaptation. Here, we presented a hy-
pothetical example in which reward data consisted of daily
adherence information available from a MEMS cap. Of
course, MEMS cap information is rarely available in real-
world settings and advances in passive sensor technologies
may expand the number of situations in which RL-based
interventions are successful in promoting behavior change.
Even without those advances, researchers should continue to
identify instances in which patients’ self-reports can be used to
guide adaptation by RL systems, since reliable behavioral
reports that are correlated in predictable ways with the out-
come of interest may be adequate, even if those self-reports
are biased relative to the actual behavior, e.g., over-reporting
of medication taking.
The mathematics needed to know how to “power” clinical
trials for RL-based systems is underdeveloped relative to what
is known for more standard fixed arms trials. The use of
simulations, as in this paper, is one approach to determining
how many patients are needed to learn a good RL policy. The
benefit of these simulations depends on the availability of
good mathematical models of patient behavior in response to
RL system actions as well as good models of noise in the
reward signal. If such models are available, then simulations
can be used to fine tune the parameters of the RL algorithm
(and more generally select from among competing RL algo-
rithms) as well as determine how many interactions with
patients are needed for the system to effectively learn what
actions are most effective for each user. Further simulation-
based and theoretical work is needed to articulate these im-
portant relationships as they apply to real-world applications,
such as SMS adherence support.
Some of the parameters we used were based on real data
(e.g., the baseline adherence rates and the expected impact of a
message addressing a patient’s adherence barriers), while
other parameters such as the distribution of adherence barriers
in the population were more arbitrary. To some extent, the
results of our simulations reflect these choices. For example, a
third of the sample in the current simulations had both con-
cerns about their medication as well as problems remembering
to take it; if those patients only had problems with forgetful-
ness, then random messages (with a third of those messages
being reminders) would have had roughly the same impact on
adherence in the overall sample as messaging exclusively
targeting forgetfulness. If baseline adherence rates were sig-
nificantly higher than the 57 % estimate we used, RL would
have less opportunity to improve over standard tailoring. In
contrast, if baseline adherence rates were much lower, then the
differences between RL and simple tailoring would be larger
than that shown in Figs. 1, 2, and 3. Auxiliary analyses that we
conducted varying these assumptions as well as others such as
the proportion of patients who misreport their adherence bar-
riers demonstrate that the relative performance of RL com-
pared to current mHealth messaging strategies would be
largely unaffected by these differences. Nevertheless, the true
benefits of an adaptive, patient-centered approach will be
situation-specific, and more research should be pursued to
understand where and how to best apply this new approach
to enhancing health behavior change.
Studies have shown repeatedly that improved adherence is
linked with improved health. For example, investigators have
reported that hypertensive patientswho are “non-adherent” have
a 3.8-fold risk of stroke-related death in 2 years [52], 43 % of
“high adherence” patients with hypertension achieve blood
pressure control compared to 33 % of those with “medium
adherence” [53], and “lower adherers” to statins have a 25 %
increased risk of death compared to “high adherers” [54]. The
precise functional form of the relationship between adherence
and health is not well described, and it is difficult to generalize
based on these simulations and available literature about specific
health benefits that could be achieved through a more adaptive
approach to behavioral intervention design. Nevertheless, it is
fair to say that the absolute improvements in adherence shown
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here relative to tailored messaging are modest, suggesting that
the details of intervention design as well as the population in
which that intervention is evaluated will be crucial determinants
of effectiveness in real-world studies of RL-based adherence
support systems. For example, auxiliary analyses indicate that if
the baseline adherence rate were only 32 %, a third of the
population did not accurately report their adherence barrier,
and if a third developed a new adherence barrier, the difference
in adherence with RL versus standard tailoring would be more
than twice that presented here.
In summary, this simulation study demonstrated the possible
benefits of RL inmHealth communication for the improvement
of medication adherence.We found that under many real-world
circumstances, RL could be more effective than tailored mes-
sages, because RL systems can learn the needs of each indi-
vidual patient and how those needs change with time. RL
systems also may provide a solution to patient burnout, by
adapting the frequency of messages to each user so that they
meet the person’s needs and preferences. RL-based mHealth
interventions are a promising example of how artificial intelli-
gence can make healthcare more patient-centered.
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